• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic Cholecystectomy for Asa III Patient\’s in Day Surgery. Why Not?

Laparoscopic Cholecystectomy for Asa III Patient\’s in Day Surgery. Why Not?

Aims. Laparoscopic cholecystectomy (LC) in day – surgery (DS) settings has become the gold standard for treatment of chronic calculosis cholecystitis.
The authors report their 4-year experience with LC to determine its safety, applicability, feasibility for selected patients. The aims of this study were to evaluate the outcome of LC for the patients with ASA III in the treatment of gallstones in Kaunas Hospital Day Surgery Centre.

Methods. A retrospective analysis was carried out on the 234 elective LC in DS settings cases dating from 2005 to 2008. 33 patients were ASA grade III. The exclusion criteria were medical: acute gallstones, diseases, ASA IV, serious associated pathology; sociales: no adult company at home, residence outside 2 hours way of the hospital.
The LC procedure was performed using a standard four-trocar technique. Operative cholangiograms were not performed. At the end of the surgery all blood, fluids and carbo dioxide were removed. The discharge criteria were: minimal discomfort, no drowsiness, oral fluids tolerated, normal urination, pain and nausea were controlled. Complications, admissions and readmissions aspects were assessed. The difference was considered to be reliable when the estimated p<0,05.

Results: 234 patients underwent LC in years 2005–2008. 193 patients were women (82,48%), 41 patients were men (17,52%). The age median of the patients was 55±14 years, range (23 – 91). The BMI (body mass index) median of the patients was 29,04 (overweight). The operative time median was 55±20 minutes (range 30-135). 50 of all patients (21,37%) had a drain placed, 184 (78,63%) had no drain placed.

33 of the 234 patients (14,10%) were ASA III patients because of cardiovascular system problems (54,55%), obesity (30,30%), diabetes (9,09%), chronic obstructive pulmonary disease etc (6,06%), whereas 147 patients had ASA grade II (62,82%), the remaining 54 patients (23,08%) had ASA grade I.

The ASA III patients were older then other remaining patients (69±13 and 52±11 years, p<0,001). ASA III were more obese then other remaining patients (BMI 32,48 and 28,61 p<0,001). The mean operative time of ASA III patients was longer then other remaining patients (58 and 55 min., p=0,40). The ASA III patients were discharged home later then other remaining patients, accordingly 19 and 15 hours after operation.

In the group of ASA III patients, a drain placed had more frequent then other remaining patients (24,24% and 20,89%); gal-bladder was found in adhesions more frequent then other remaining patients (75,76% and 61,19%). In the group of ASA III patients, a anticoagulation therapy was using had more frequent then other remaining patients (18,18% and 1,49%).

In ASA III patients group were really severer patients then in I and II ASA patients group, but there were no conversions to open procedures. There was no bleeding, no visceral injury, and no mortality.
Conclusions. LC in DS settings seems to be a safe, effective and feasible intervention for selected patients, even they had ASA grade III, with high level of patient satisfaction and economic benefit for the hospital.


Session: Poster

Program Number: P493

View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search